drugset / Trial / NCT03612323

Comparison Between Intraligamentary Piroxicam and Articaine

NCT03612323

Phase 0 Unknown 20 enrolled Cairo University
RandomizedParallel-groupTriple-blindPrevention

Summary

Comparing the efficacy of intra-ligamentary Piroxicam and intra-ligamentary Articaine on pain during and after endodontic treatment of mandibular molars with symptomatic irreversible pulpitis.

Timeline

Start
2018-11
Primary completion
2019-05
Completion
2019-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Articaine Other / unclassified 0.4 ml Other
Comparator Articaine Other / unclassified 4 % Other
Subject Piroxicam Unknown 0.4 ml Other
Subject Piroxicam Unknown 20 mg Other

Indications